These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36252242)

  • 1. Brief Report: Financial Burden of Toxoplasmosis Encephalitis Treatment at a Safety Net Hospital.
    Bogard SN; Lee JT; Patel M; Kempker RR
    J Acquir Immune Defic Syndr; 2022 Nov; 91(3):276-279. PubMed ID: 36252242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting the Evidence Base for Modern-Day Practice of the Treatment of Toxoplasmic Encephalitis: A Systematic Review and Meta-Analysis.
    Prosty C; Hanula R; Levin Y; Bogoch II; McDonald EG; Lee TC
    Clin Infect Dis; 2023 Feb; 76(3):e1302-e1319. PubMed ID: 35944134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017.
    Belk K; Connolly MP; Schlesinger L; Ben-Harari RR
    Pathog Glob Health; 2018 Dec; 112(8):428-437. PubMed ID: 30526421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review.
    Ben-Harari RR; Goodwin E; Casoy J
    Drugs R D; 2017 Dec; 17(4):523-544. PubMed ID: 28879584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasmosis Encephalitis: A Cross-Sectional Analysis at a U.S. Safety-Net Hospital in the Late cART Era.
    Lau A; Jain MK; Chow JY; Kitchell E; Lazarte S; Nijhawan A
    J Int Assoc Provid AIDS Care; 2021; 20():23259582211043863. PubMed ID: 34663116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
    Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N
    Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis.
    Connolly MP; Goodwin E; Schey C; Zummo J
    Pathog Glob Health; 2017 Feb; 111(1):31-44. PubMed ID: 28090819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
    Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
    N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G
    AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings).
    Dedicoat M; Livesley N
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005420. PubMed ID: 16856096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.
    Dunay IR; Heimesaat MM; Bushrab FN; Müller RH; Stocker H; Arasteh K; Kurowski M; Fitzner R; Borner K; Liesenfeld O
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4848-54. PubMed ID: 15561866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcome.
    Van Delden C; Hirschel B
    J Infect Dis; 1996 May; 173(5):1294-5. PubMed ID: 8627092
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
    Podzamczer D; Miró JM; Bolao F; Gatell JM; Cosín J; Sirera G; Domingo P; Laguna F; Santamaría J; Verdejo J
    Ann Intern Med; 1995 Aug; 123(3):175-80. PubMed ID: 7598298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
    Hernandez AV; Thota P; Pellegrino D; Pasupuleti V; Benites-Zapata VA; Deshpande A; Penalva de Oliveira AC; Vidal JE
    HIV Med; 2017 Feb; 18(2):115-124. PubMed ID: 27353303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group.
    Leport C; Chêne G; Morlat P; Luft BJ; Rousseau F; Pueyo S; Hafner R; Miro J; Aubertin J; Salamon R; Vildé JL
    J Infect Dis; 1996 Jan; 173(1):91-7. PubMed ID: 8537688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS.
    Jacobson JM; Hafner R; Remington J; Farthing C; Holden-Wiltse J; Bosler EM; Harris C; Jayaweera DT; Roque C; Luft BJ;
    AIDS; 2001 Mar; 15(5):583-9. PubMed ID: 11316995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse of Toxoplasma encephalitis and susceptibility to pyrimethamine: lack of evidence of treatment-induced resistance.
    Caramello P; Brancale T; Forno B; Lucchini A; Pollono AM; Ullio A; Gioannini P; Viano I; Tonso E
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2371-2. PubMed ID: 8619602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.